|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Net earned premium | |||||
| Net investment income | |||||
| Net realized and unrealized investment losses | |||||
| Net realized and unrealized investment gains (losses) from related party investment funds | |||||
| Net investment income and net realized and unrealized investment losses | |||||
| Other revenues | |||||
| Loss on settlement and change in fair value of liability-classified capital instruments | |||||
| Total revenues | |||||
| Expenses | |||||
| Loss and loss adjustment expenses incurred, net | |||||
| Acquisition costs, net | |||||
| Other underwriting expenses | |||||
| Net corporate and other expenses | |||||
| Intangible asset amortization | |||||
| Interest expense | |||||
| Foreign exchange (gains) losses | |||||
| Total expenses | |||||
| Income before income tax (expense) benefit | |||||
| Income tax (expense) benefit | |||||
| Net income | |||||
| Net income attributable to noncontrolling interests | |||||
| Net income available to SiriusPoint | |||||
| Dividends on Series B preference shares | |||||
| Net income available to SiriusPoint common shareholders, basic | |||||
| Net income available to SiriusPoint common shareholders, diluted | |||||
| Earnings per share available to SiriusPoint common shareholders | |||||
| Basic earnings per share available to SiriusPoint common shareholders (in dollars per share) | |||||
| Diluted earnings per share available to SiriusPoint common shareholders (in dollars per share) | |||||
| Weighted average number of common shares used in the determination of earnings per share | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...